USA – FDA issues final guidance on de novo approvals

The FDA has released final guidance to clarify exactly what medtech companies need to include in their requests for the agency to review their applications for de novo approval.

The agency said it updated the guidance to comply with the Medical Device User Fee Amendments of 2017 goal to speed the product review process and to get safe and effective novel devices to the public…